# Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years

> **NCT01883531** · PHASE2 · COMPLETED · sponsor: **Syntara** · enrollment: 95 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Inhaled Mannitol
- **DRUG:** Inhaled Placebo

## Key facts

- **NCT ID:** NCT01883531
- **Lead sponsor:** Syntara
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2015-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01883531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01883531, "Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01883531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*